Publication
Number of items: 7.
1 March 2020
  • Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of Novel Psychoactive Substances. (2020) Elena Deligianni, Omari-Jordan Daniel, John Corkery, Fabrizio Schifano and Lisa Lione
    • 14 January 2020
  • How deaths can help clinicians and policy-makers understand the risks of Novel Psychoactive Substances. (2020) John Corkery, Fabrizio Schifano and Giovanni Martinotti
    • 1 November 2019
  • The clinical challenges of synthetic cathinones. (2019) Fabrizio Schifano, Flavia Napoletano, Davide Arillotta, Caroline Zangani, Liam Gilgar, Amira Guirguis, John Corkery and Alessandro Vento
    • 2013
  • Comparative Efficacy and Tolerability of Antiepileptic Drugs for Refractory Focal Epilepsy Systematic Review and Network Meta-Analysis reveals the need for long-term comparator trials. (2013) Pritesh N. Bodalia, Anthony M. Grosso, Reecha Sofat, Raymond J. Macallister, Liam Smeeth, S. Dhillon, Juan-Pablo Casas, David Wonderling and Aroon D. Hingorani
    • 2011
  • Deaths of opiate/opioid misusers involving dihydrocodeine, UK, 1997 - 2007. (2011) G. Zamparutti, Fabrizio Schifano, John Corkery, A. Oyefeso and A. Hamid Ghodse
    • 1997
  • A prospective study of the effects of prolonged timolol therapy on α- and β-adrenoceptor and angiotensin II receptor mediated responses in normal subjects. (1997) A. Ferro, J.A. Hall, Claire Dickerson and M.J. Brown
    • 1991
  • Prolonged effect of CGRP in Raynaud's patients : a double-blind randomised comparison with prostacyclin. (1991) S. Shawket, Claire Dickerson, B. Hazleman and M.J. Brown